US OptionsDetailed Quotes

VKTX241213C57000

Watchlist

0.05
0.000.00%

15min DelayClose Dec 13 16:00 ET

0.05High0.02Low

Viking Therapeutics Stock Discussion

10xStockPicks

11 hours ago

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...

ChrissyGee

22 hours ago

Covered call options have been my residual income with $Viking Therapeutics (VKTX.US)$

Understanding the Premium

72792912

Dec 10 12:36

$Viking Therapeutics (VKTX.US)$ the only thing you need is endurance for this stock!

Dannymite

Dec 9 14:38

Literally a straight line

$Viking Therapeutics (VKTX.US)$ Not high enough for me to sell, not low enough for me to buy more...

Clay Bay

Dec 9 13:48

I know vktx will have a comeback

$Viking Therapeutics (VKTX.US)$ down now but I'm not concerned. Those in the know, know what's about to happen that'swhy they bought a covered call from me for $100. This pharmaceutical is ready for 🚀 with a new drug on the horizon.

HugoV

Dec 6 09:24

Next week we fly.

$Viking Therapeutics (VKTX.US)$ finally bottomed. time for some gains!

72792912

Dec 3 11:40

$Viking Therapeutics (VKTX.US)$ don’t worry. VK2809 is enough to support the price of this stock to reach 100 and even higher

Dannymite

Dec 3 11:27

It seems like going to a major downfall, it's about to hit the support point and heading to a "death cross".

$Viking Therapeutics (VKTX.US)$

Hanh Tran384

Dec 3 09:00

Can anyone tell me what is going on with VKTX now?? It is keep falling down even after good news?? 🥲

$Viking Therapeutics (VKTX.US)$

Shaaaw

Nov 27 06:52

Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...

No comment yet